Hudson Portfolio Management LLC Acquires Shares of 25,873 CVS Health Corporation $CVS

Hudson Portfolio Management LLC bought a new stake in CVS Health Corporation (NYSE:CVS) during the second quarter, HoldingsChannel.com reports. The firm bought 25,873 shares of the pharmacy operator’s stock, valued at approximately $2,677,000. CVS Health accounts for approximately 2.0% of Hudson Portfolio Management LLC’s portfolio, making the stock its 12th biggest holding.

Other institutional investors also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd lifted its position in shares of CVS Health by 407.2% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares during the last quarter. Swiss RE Ltd. acquired a new position in CVS Health during the fourth quarter worth about $26,000. Kilter Group LLC bought a new position in shares of CVS Health in the second quarter worth about $27,000. Sankala Group LLC bought a new position in shares of CVS Health in the fourth quarter worth about $28,000. Finally, Global Trust Asset Management LLC boosted its stake in shares of CVS Health by 344.8% in the 1st quarter. Global Trust Asset Management LLC now owns 387 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 300 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of several research reports. Mizuho lifted their price target on shares of CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Piper Sandler reissued an “overweight” rating and issued a $113.00 price objective on shares of CVS Health in a research note on Monday, June 1st. Robert W. Baird set a $107.00 target price on shares of CVS Health in a research report on Thursday, August 6th. Wall Street Zen upgraded shares of CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Finally, Argus increased their price target on CVS Health from $104.00 to $114.00 and gave the company a “buy” rating in a research note on Wednesday. Twenty-two investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, CVS Health presently has an average rating of “Moderate Buy” and an average target price of $107.17.

CVS Health Stock Down 0.7%

Shares of NYSE CVS opened at $93.01 on Friday. The company has a 50 day simple moving average of $102.02 and a 200 day simple moving average of $88.86. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The firm has a market cap of $118.96 billion, a PE ratio of 24.61, a price-to-earnings-growth ratio of 0.85 and a beta of 0.61.

CVS Health (NYSE:CVS) last announced its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion during the quarter, compared to analysts’ expectations of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The company’s revenue was up 7.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts forecast that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a yield of 2.9%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s dividend payout ratio (DPR) is currently 70.37%.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.